The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-based Injectable Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brand
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Peptide-based Injectable Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-based Injectable Drugs Market Perspective (2018-2029)
2.2 Peptide-based Injectable Drugs Growth Trends by Region
2.2.1 Global Peptide-based Injectable Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peptide-based Injectable Drugs Historic Market Size by Region (2018-2023)
2.2.3 Peptide-based Injectable Drugs Forecasted Market Size by Region (2024-2029)
2.3 Peptide-based Injectable Drugs Market Dynamics
2.3.1 Peptide-based Injectable Drugs Industry Trends
2.3.2 Peptide-based Injectable Drugs Market Drivers
2.3.3 Peptide-based Injectable Drugs Market Challenges
2.3.4 Peptide-based Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-based Injectable Drugs Players by Revenue
3.1.1 Global Top Peptide-based Injectable Drugs Players by Revenue (2018-2023)
3.1.2 Global Peptide-based Injectable Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Peptide-based Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide-based Injectable Drugs Revenue
3.4 Global Peptide-based Injectable Drugs Market Concentration Ratio
3.4.1 Global Peptide-based Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Injectable Drugs Revenue in 2022
3.5 Peptide-based Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Peptide-based Injectable Drugs Product Solution and Service
3.7 Date of Enter into Peptide-based Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-based Injectable Drugs Breakdown Data by Type
4.1 Global Peptide-based Injectable Drugs Historic Market Size by Type (2018-2023)
4.2 Global Peptide-based Injectable Drugs Forecasted Market Size by Type (2024-2029)
5 Peptide-based Injectable Drugs Breakdown Data by Application
5.1 Global Peptide-based Injectable Drugs Historic Market Size by Application (2018-2023)
5.2 Global Peptide-based Injectable Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Peptide-based Injectable Drugs Market Size (2018-2029)
6.2 North America Peptide-based Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Peptide-based Injectable Drugs Market Size by Country (2018-2023)
6.4 North America Peptide-based Injectable Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-based Injectable Drugs Market Size (2018-2029)
7.2 Europe Peptide-based Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Peptide-based Injectable Drugs Market Size by Country (2018-2023)
7.4 Europe Peptide-based Injectable Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-based Injectable Drugs Market Size (2018-2029)
8.2 Asia-Pacific Peptide-based Injectable Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Peptide-based Injectable Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Peptide-based Injectable Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-based Injectable Drugs Market Size (2018-2029)
9.2 Latin America Peptide-based Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Peptide-based Injectable Drugs Market Size by Country (2018-2023)
9.4 Latin America Peptide-based Injectable Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-based Injectable Drugs Market Size (2018-2029)
10.2 Middle East & Africa Peptide-based Injectable Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Peptide-based Injectable Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Peptide-based Injectable Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-based Injectable Drugs Introduction
11.1.4 Sanofi Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-based Injectable Drugs Introduction
11.2.4 Teva Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-based Injectable Drugs Introduction
11.3.4 Novo Nordisk Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-based Injectable Drugs Introduction
11.4.4 Takeda Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-based Injectable Drugs Introduction
11.5.4 Eli Lilly Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-based Injectable Drugs Introduction
11.6.4 AstraZeneca Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-based Injectable Drugs Introduction
11.7.4 Novartis Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-based Injectable Drugs Introduction
11.8.4 AbbVie Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Detail
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-based Injectable Drugs Introduction
11.9.4 Ipsen Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Detail
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-based Injectable Drugs Introduction
11.10.4 Ferring Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-based Injectable Drugs Introduction
11.11.4 Merck Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Detail
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-based Injectable Drugs Introduction
11.12.4 The Medicines Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.12.5 The Medicines Recent Development
11.13 Roche
11.13.1 Roche Company Detail
11.13.2 Roche Business Overview
11.13.3 Roche Peptide-based Injectable Drugs Introduction
11.13.4 Roche Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.13.5 Roche Recent Development
11.14 J & J
11.14.1 J & J Company Detail
11.14.2 J & J Business Overview
11.14.3 J & J Peptide-based Injectable Drugs Introduction
11.14.4 J & J Revenue in Peptide-based Injectable Drugs Business (2018-2023)
11.14.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details